Literature DB >> 19066128

Determinants of human and mouse melanoma cell sensitivities to oleandrin.

Yun Lin1, William P Dubinsky, Dah H Ho, Edward Felix, Robert A Newman.   

Abstract

Oleandrin, a cardiac glycoside component of Nerium oleander, has been shown to induce apoptosis in malignant cells. While human tumor cells are very sensitive to growth inhibition by oleandrin, murine tumor cells are extremely resistant. Using human BRO and mouse B16 melanoma cell lines, we explored several possible determinants of cell sensitivity to oleandrin and compared with ouabain. The studies include Na+, K(+)-ATPase activity and its isoforms as well as the cellular uptake of these cardiac glycosides. Oleandrin and ouabain induced apoptosis was detected in BRO cells while no evidence of cell death was observed in B16 cells even at concentrations 1000-fold higher than that used for BRO cells. Cellular uptake of oleandrin and ouabain was 3-4 fold greater in human BRO tumor cells than murine tumor cells. Partially purified Na+, K(+)-ATPase from human BRO cells was inhibited at a concentration that was 1000-fold less than that was required to inhibit mouse B16 enzyme to the same extent. Using Western blot analyses, human BRO cells were found to express both the sensitive alpha3 isoform and the less sensitive alpha1 isoform of Na+, K(+)-ATPase while mouse B16 cells expressed only the alpha1 isoform. These data suggest that differential expressions of Na+, K(+)-ATPase activities and its isoforms in BRO and B16 cells as well as cellular drug uptake may be important determinants of tumor cell sensitivity to cardiac glycosides.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066128

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  8 in total

1.  The Glycoside Oleandrin Reduces Glioma Growth with Direct and Indirect Effects on Tumor Cells.

Authors:  Stefano Garofalo; Alfonso Grimaldi; Giuseppina Chece; Alessandra Porzia; Stefania Morrone; Fabrizio Mainiero; Giuseppina D'Alessandro; Vincenzo Esposito; Barbara Cortese; Silvia Di Angelantonio; Flavia Trettel; Cristina Limatola
Journal:  J Neurosci       Date:  2017-03-14       Impact factor: 6.167

2.  Cellular location and expression of Na+, K+ -ATPase α subunits affect the anti-proliferative activity of oleandrin.

Authors:  Peiying Yang; Carrie Cartwright; Ekem Efuet; Stanley R Hamilton; Ignacio Ivan Wistuba; David Menter; Crandell Addington; Imad Shureiqi; Robert A Newman
Journal:  Mol Carcinog       Date:  2012-10-16       Impact factor: 4.784

3.  A novel cell-based high-throughput screen for inhibitors of HIV-1 gene expression and budding identifies the cardiac glycosides.

Authors:  Gregory M Laird; Evelyn E Eisele; S Alireza Rabi; Daria Nikolaeva; Robert F Siliciano
Journal:  J Antimicrob Chemother       Date:  2013-11-24       Impact factor: 5.790

4.  Antioxidant, anti-inflammatory, anti-apoptotic, and skin regenerative properties of an Aloe vera-based extract of Nerium oleander leaves (nae-8(®)).

Authors:  Kathleen F Benson; Robert A Newman; Gitte S Jensen
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-05-06

5.  Trial watch: Cardiac glycosides and cancer therapy.

Authors:  Laurie Menger; Erika Vacchelli; Oliver Kepp; Alexander Eggermont; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-02-01       Impact factor: 8.110

Review 6.  Oleandrin: A cardiac glycosides with potent cytotoxicity.

Authors:  Arvind Kumar; Tanmoy De; Amrita Mishra; Arun K Mishra
Journal:  Pharmacogn Rev       Date:  2013-07

7.  Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.

Authors:  Alison W Ashbrook; Anthony J Lentscher; Paula F Zamora; Laurie A Silva; Nicholas A May; Joshua A Bauer; Thomas E Morrison; Terence S Dermody
Journal:  mBio       Date:  2016-05-24       Impact factor: 7.867

8.  Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma.

Authors:  Ugur Eskiocak; Vijayashree Ramesh; Jennifer G Gill; Zhiyu Zhao; Stacy W Yuan; Meng Wang; Travis Vandergriff; Mark Shackleton; Elsa Quintana; Timothy M Johnson; Ralph J DeBerardinis; Sean J Morrison
Journal:  Nat Commun       Date:  2016-08-22       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.